Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №5 (2025) > Quality of life in overweight and obese postmenopausal women

Quality of life in overweight and obese postmenopausal women

Marina V. Danilova , Elena N. Usoltseva , Natalia K. Vereina

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Aim. To assess the quality of life, including sleep quality, and the severity of climacteric syndrome (CS) in overweight and obese women compared to women with normal body weight in the postmenopausal period.
Materials and methods. A cross-sectional study of 92 women aged 47–60 years was conducted. The general SF-36 questionnaire and a special Women's Health Questionnaire (WHQ) were used to study the level of quality of life. The presence of CS was assessed by calculating the modified menopausal index (MMI), the Green scale, and the visual analogue scale for hot flashes and hyperhidrosis. To assess sleep disorders, the Epworth Sleepiness Scale and the Subjective Sleep Characteristics Scoring Questionnaire were used. The main group consisted of overweight and obese women (n=58), the control group consisted of women with normal body weight (n=34).
Results. Overweight and obese women, compared with women with normal body weight, had lower quality of life (SF-36) scores on the scales of physical functioning (p<0.001), pain intensity (p=0.028), general health (p=0.008) and vitality (p=0.003), as well as on the scales of the WHQ questionnaire: somatic symptoms, memory/attention and vasomotor symptoms. Women in the main group had more pronounced symptoms of CS than in the control group: 22 points versus 12, respectively, according to the results of the MMI (p<0.001), 21 points versus 7.5 on the Greene scale (p=0.008). Daytime sleepiness was 2 times more common in the main group than in the control group (35.2% vs 14.7%, p=0.049).The analysis of questionnaires for scoring subjective sleep characteristics did not reveal differences in the frequency of sleep disorders between the groups (42.6% vs 23.5%, p=0.068), however, lower scores were obtained in the main group compared with the control group (18.91±3.22 vs. 20.65±3.27, p=0.016).
Conclusion. The obtained results should be taken into account for personalization of treatment of postmenopausal women with metabolic and endocrine disorders by both obstetricians-gynecologists and related specialists – general practitioners, endocrinologists.
Key words: postmenopause, obesity, quality of life, SF-36, WHQ, sleep quality, climacteric syndrome.

About the Author

Marina V. Danilova 1 , Elena N. Usoltseva 1 , Natalia K. Vereina 1

1 South Ural State Medical University, Chelyabinsk, Russia

References

1. Chikwati RP, Chikowore T, Mahyoodeen NG et al. The association of menopause with cardiometabolic disease risk factors in low- and middle-income countries: a systematic review and meta-analyses. Menopause 2024;31(1):77-85.
2. Marlatt KL, Pitynski-Miller DR, Gavin KM et al. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring) 2022;30(1):14-27.
3. Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol 2022;10(6):442-56.
4. Samargandy S, Matthews KA, Brooks MM et al. Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: the SWAN heart study. Menopause 2021;28(6):626-33.
5. https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight
6. https://data.who.int/ru/indicators/i/C6262EC/BEFA58B
7. Юсенко С.Р., Зубкова Т.С., Сорокин А.С., Халтурина Д.А. Ожирение в России: динамика распространенности и половозрастная структура с конца XX века. Общественное здоровье. 2024;4(3):17-29.
8. Nappi RE, Kroll R, Siddiqui E et al. Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden. Menopause 2021;28(8):875-82.
9. Palacios S, Chedraui P, Sánchez-Borrego R et al. Obesity and menopause. Gynecol Endocrinol 2024;40(1):2312885.
10. Alblooshi S, Taylor M, Gill N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry 2023;31(2):165-73.
11. Hurtado MD, Saadedine M, Kapoor E et al. Weight Gain in Midlife Women. Curr Obes Rep 2024;13(2):352-63.
12. Greendale GA, Sternfeld B, Huang M et al. Changes in body composition and weight during the menopause transition. JCI Insight 2019;4(5):e124865, 124865.
13. Hallajzadeh J, Khoramdad M, Izadi N et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause 2018;25(10):1155.
14. Moudi A, Dashtgard A, Salehiniya H et al. The relationship between health-promoting lifestyle and sleep quality in postmenopausal women. Biomedicine (Taipei) 2018;8(2):11.
15. Verde L, Barrea L, Vetrani C et al. Chronotype and Sleep Quality in Obesity: How Do They Change After Menopause? Curr Obes Rep 2022;11(4):254-62.
16. Данилова М.В., Усольцева Е.Н. Роль гормона эпифиза мелатонина в сохранении здоровья женщин репродуктивного возраста (обзор литературы). Акушерство, гинекология и репродукция. 2019;13(4):337-44.
Danilova M.V., Usoltseva E.N. The role of the pineal gland hormone melatonin in maintaining the health of women of reproductive age (literature review). Obstetrics, Gynecology and Reproduction. 2019;13(4):337-44 (in Russian).
17. Сандакова Е.А., Жуковская И.Г. Особенности течения периода менопаузального перехода и ранней постменопаузы у женщин с различными типами и степенью ожирения. РМЖ. Мать и дитя. 2019;2(1):16-22.
Sandakova E.A., Zhukovskaya I.G. Features of the course of the menopausal transition period and early postmenopause in women with different types and degrees of obesity. RMJ. Mother and Child. 2019;2(1):16-22 (in Russian).
18. Harlow SD, Gass M, Hall JE et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 2012;19(4):387.
19. Брюхина Е.В., Усольцева Е.Н. Мелатонин – ключ к адаптации женского организма при климактерическом синдроме. Врач. 2016;(4):68-71.
Bryukhina E.V., Usoltseva E.N. Melatonin – the key to adaptation of the female body during climacteric syndrome. Doctor. 2016;(4):68-71 (in Russian).
20. Потемина Т.Е., Кузнецова С.В., Перешеин А.В. и др. Качество жизни в здравоохранении: критерии, цели, перспективы. Российский остеопатический журнал. 2018;(3-4):98-106.
Potemina T.E., Kuznetsova S.V., Pereshein A.V., et al. Quality of life in healthcare: criteria, goals, prospects. Russian Osteopathic Journal. 2018;(3-4):98-106 (in Russian).
21. Hunter MS. The Women’s Health Questionnaire (WHQ): Frequently Asked Questions (FAQ). Health and Quality of Life Outcomes 2003;1(1):1-5.
22. Lynch CP, McTigue KM, Bost JE et al. Excess weight and physical health-related quality of life in postmenopausal women of diverse racial/ethnic backgrounds. J Womens Health (Larchmt) 2010;19(8):1449-58.
23. Korhonen PE, Seppälä T, Järvenpää S, Kautiainen H. Body mass index and health-related quality of life in apparently healthy individuals. Qual Life Res 2014;23(1):67-74.
24. Ghazanfarpour M, Abdolahian S, Zare M, Shahsavari S. Association between anthropometric indices and quality of life in menopausal women. Gynecol Endocrinol 2013;29(10):917-20.
25. Williams LT, Young AF, Brown WJ. Weight gained in two years by a population of mid-aged women: how much is too much? Int J Obes (Lond) 2006;30(8):1229-33.
26. Llaneza P, Iñarrea J, Gonzalez C et al. Differences in health related quality of life in a sample of Spanish menopausal women with and without obesity. Maturitas 2007;58(4):387-94.
27. Dotlic J, Radovanovic S, Rancic B et al. Mental health aspect of quality of life in the menopausal transition. J Psychosom Obstet Gynaecol 2021;42(1):40-9.
28. Hutchings HA, Taylor N, Remesh A, Rafferty J. A study evaluating quality of life and factors affecting it before, during and after menopause. Eur J Obstet Gynecol Reprod Biol 2023;(289):100-7.
29. Maggio Da Fonseca A, Bagnoli VR, Souza MA et al. Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol 2013;29(2):116-8.
30. Yokota M, Makita K, Hirasawa A et al. Symptoms and effects of physical factors in Japanese middle-aged women. Menopause 2016;23(9):974-83.
31. Castelo-Branco C, Palacios S, Ferrer-Barriendos J et al. Impact of anthropometric parameters on quality of life during menopause. Fertil Steril 2009;92(6):1947-52.
32. Saccomani S, Lui-Filho JF, Juliato CR et al. Does obesity increase the risk of hot flashes among midlife women: a population-based study. Menopause 2017;24(9):1065-70.
33. Gold EB, Crawford SL, Shelton JF et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women’s Health Across the Nation (SWAN). Menopause 2017;24(1):9-26.
34. Martínez-Vázquez S, Hernández-Martínez A, Peinado-Molina RA, Martínez-Galiano JM. Impact of overweight and obesity in postmenopausal women. Climacteric 2023;26(6):577-82.
35. Iftikhar IH, Hoyos CM, Phillips CL, Magalang UJ. Meta-analyses of the Association of Sleep Apnea with Insulin Resistance, and the Effects of CPAP on HOMA-IR, Adiponectin, and Visceral Adipose Fat. J Clin Sleep Med 2015;11(4):475-85.
36. Taylor BJ, Matthews KA, Hasler BP et al. Bedtime Variability and Metabolic Health in Midlife Women: The SWAN Sleep Study. Sleep 2016;39(2):457-65.
37. Pyykkönen AJ, Isomaa B, Pesonen AK et al. Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes. Diabetes Care 2012;35(11):2271-8.
38. Kline CE, Hall MH, Buysse DJ et al. Poor Sleep Quality is Associated with Insulin Resistance in Postmenopausal Women With and Without Metabolic Syndrome. Metab Syndr Relat Disord 2018;16(4):
183-9.
39. Greenblum CA, Rowe MA, Neff DF, Greenblum JS. Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life. Menopause 2013;20(1):22-7.

Портал CON-MED.RU:
https://con-med.ru/magazines/klinicheskiy_razbor_v_obshchey_meditsine/klinicheskiy_razbor_v_obshchey_meditsine-05-2025/kachestvo_zhizni_zhenshchin_s_izbytochnoy_massoy_tela_i_ozhireniem_v_postmenopauze/

For citation: Danilova M.V., Usoltseva E.N., Vereina N.K. Quality of life in overweight and obese postmenopausal women. Clinical review for general practice. 2025; 6 (5): 94–99 (In Russ.). DOI: 10.47407/kr2025.6.05.00p4532


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru